One of the biggest threats to scientific innovation has always been the lack of capital. Venture capital only really makes sense if companies can grow rapidly, and most other equity investments tend to be illiquid until an exit is found. Brian McConnel at Gigacom takes a look at ‘Class R’ stock, a possible investment model that is halfway between a …
Credit Crunch or Creative Destruction
In October 2008, I was asked at the World Economic Forum along with other experts to address the main challenges facing nanotechnology. While environmental, health and safety concerns had been the preoccupation of many for 2008, this question posed by the WEF combined with the world economic crisis led me to consider the challenges of funding and commercializing of nanotechnology …
Global Crown Capital and Nanodynamics
Darrell Brookstein at Nanotechnology.com casts more light on the Nanodynamics IPO that wasn’t… “In mid 2007 and into last week, one single, unlucky investment bank raised ARWR $16.5 million at $5.78 per share with ¼ warrants at $7.06 (it’s now $2.10). They raised NANX $10.6 million at $5.92 (now $3.21). Now, oddly, they were unable, for whatever reason (amazed neither …